Is Tactile Systems Technology, Inc. (TCMD) Overvalued?
We dive into why Tactile Systems Technology, Inc. (TCMD) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Michael Rose
Stock Evaluator: Tactile Systems Technology, Inc. (TCMD)
Tactile Systems Technology, Inc. TCMD
$23.40
-0.03
-0.13%
August 21, 2026 12:14:00 PM
EST
Volume: 100,000
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Commentary & Analysis
Why Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 15.01%
As of Tuesday, August 11, Tactile Systems Technology, Inc.’s TCMD share price has dipped by 15.01%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 14.82%
As of Tuesday, August 11, Tactile Systems Technology, Inc.’s TCMD share price has dipped by 14.82%, which has investors questioning if this is right time to buy.Michael Rose
What You Need to Know About Tactile Systems Technology, Inc.'s Q3 Earnings
Tactile Systems Technology, Inc.'s fiscal Q3 earnings report was released on Monday, August 10. Let's dive in to see if (TCMD) missed or beat analyst's expectations.Jenna Brashear
Why Tactile Systems Technology, Inc.’s (TCMD) Stock Is Up 5.25%
As of Thursday, June 04, Tactile Systems Technology, Inc.’s TCMD share price has surged by 5.25%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | TCMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $530.7 | $407.7 | 37% |
|
| Shares Out (Mil) | 23.1 | 41.3 | 32% |
|
| Institutional Ownership | 97.6% | 81.4% | 75% |
|
| Float (Mil) | 20.6 | 34.9 | 29% |
|
| Beta | 0.82 | 0.88 | 49% |
|
| Avg Daily Volume (000s) | 547 | 412 | 59% |
|
| Price Change (52-week) |
82.2% | 64.8% | 88% |
|
| Growth | TCMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.0% | 11.8% | 65% |
|
| Net Income (5yr) | 102.2% | (6.0%) | 99% |
|
| EPS (5yr) | 94.2% | 10.4% | 99 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.8%) | (16.2%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | $0.335 | $1.165 | $1.455 | |
| Month Ago EPS | $0.390 | $1.095 | $1.505 | |
| # Rev Up | 2 | 0 | 2 | |
| # Rev Down | 0 | 2 | 0 | |
| Three Months Ago EPS | $0.390 | $1.095 | $1.505 | |
| Year/Year Chg | (1.5%) | 42.1% | 162.2% | |
| Financials | TCMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $350 | $119 | 37% |
|
| Net Income (TTM) (Mil) | $25 | ($9) | 50% |
|
| EPS (TTM) | $1.106 | ($0.400) | 62% |
|
| Operating Cash Flow (TTM) (Mil) | $31 | ($3) | 44% |
|
| Net Cash Flow (TTM) (Mil) | ($12) | $1 | 29% |
|
| Long-Term Debt (Q1) (Mil) | $11 | $21 | 29% |
|
| Enterprise Value (Q1) (Mil) | $500 | $427 | 34% |
|
| Valuation | TCMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.38 | 3.06 | 56% |
|
| P/E | 21.7 | 27.8 | 55% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.2 | 1.7 | 10% |
|
| Ratios | TCMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 76.8% | 58.9% | 87% |
|
| Net Margin | 7.1% | (6.9%) | 55% |
|
| ROA | 9.0% | (12.7%) | 85% |
|
| ROE | 11.9% | (13.1%) | 63% |
|
| Liabilities to Assets | 20.0% | 46.0% | 13% |
|
| F-Score | 9 | 4 | 98% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Price-to-Sales Screen
Factors: Value, Growth
Research indicates that using price-to-sales ratios may lead to better investment results than price-to-book-value ratios or price-earnings ratios.
| Performance Since Inception: | 13.0% |
| +/- S&P 500: | +5.5 |
GURU STRATEGY
Wanger Screen
Factors: Value, Size, Growth
First introduced in May 1997, this approach focuses on limiting the risks of investing in small-cap stocks.
| Performance Since Inception: | 12.1% |
| +/- S&P 500: | +4.6 |
